drugset / Trial / NCT02700685

Effect of Pycnogenol® on ADHD

NCT02700685

Phase 3 Completed 88 enrolled Nina Hermans
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This double blind, randomised controlled trial examines the effect of a commercially available nutritional supplement on behaviour of ADHD patients, as well as on their physical and psychiatric co-morbidities, and level of oxidative stress and immune activity, as compared to placebo and standard pharmaceutical treatment for ADHD.

Timeline

Start
2017-09-01
Primary completion
2020-11-20
Completion
2020-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule 20 mg
Comparator Methylphenidate Small molecule 30 mg